✉ Email this page to a colleague
« Back to Dashboard
Mitoquinone is an investigational drug.
There have been 9 clinical trials for Mitoquinone. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., University of Colorado, Boulder, and MitoQ Ltd.
Recent Clinical Trials for Mitoquinone
|An Open Label Study in Healthy Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate as Prophylaxis for Development of Severe Viral Illness||University of California, Los Angeles||Phase 1/Phase 2|
|The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients||InCor Heart Institute||N/A|
|The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients||Instituto do Cancer do Estado de São Paulo||N/A|